Dialysis for iron? new device offers hope for patients who Can't take standard pills
NCT ID NCT06781099
Summary
This study is testing a medical device called MEX-CD1 that works like dialysis to filter excess iron from the blood. It is for patients with myelodysplastic syndrome or myelofibrosis who need regular blood transfusions, which cause dangerous iron buildup, but who cannot tolerate the standard oral or injectable medications to reduce iron. The main goals are to see if the device is safe, feasible to use, and effective at lowering iron levels, while also checking if it reduces the need for transfusions and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Lyon Sud
RECRUITINGOullins-Pierre-Bénite, 69495, France
-
Hôpital Lyon Sud
RECRUITINGOullins-Pierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.